SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-112189
Filing Date
2022-10-28
Accepted
2022-10-28 08:00:49
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K aciu-20220930x6k.htm   iXBRL 6-K 99328
2 EXHIBIT 99.1 aciu-20220930xex99d1.htm   iXBRL EX-99.1 858959
3 EXHIBIT 99.2 aciu-20220930xex99d2.htm EX-99.2 348481
4 EXHIBIT 99.3 aciu-20220930xex99d3.htm EX-99.3 233968
10 GRAPHIC aciu-20220930xex99d3001.jpg GRAPHIC 3076
  Complete submission text file 0001104659-22-112189.txt   5397341

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aciu-20220930.xsd EX-101.SCH 50642
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aciu-20220930_cal.xml EX-101.CAL 52090
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aciu-20220930_def.xml EX-101.DEF 135023
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aciu-20220930_lab.xml EX-101.LAB 394847
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aciu-20220930_pre.xml EX-101.PRE 290745
62 EXTRACTED XBRL INSTANCE DOCUMENT aciu-20220930x6k_htm.xml XML 890579
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 221339028
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences